全文获取类型
收费全文 | 9760篇 |
免费 | 918篇 |
国内免费 | 362篇 |
专业分类
耳鼻咽喉 | 25篇 |
儿科学 | 141篇 |
妇产科学 | 69篇 |
基础医学 | 586篇 |
口腔科学 | 183篇 |
临床医学 | 2104篇 |
内科学 | 3035篇 |
皮肤病学 | 94篇 |
神经病学 | 733篇 |
特种医学 | 121篇 |
外国民族医学 | 2篇 |
外科学 | 444篇 |
综合类 | 1479篇 |
现状与发展 | 4篇 |
预防医学 | 174篇 |
眼科学 | 60篇 |
药学 | 1123篇 |
3篇 | |
中国医学 | 446篇 |
肿瘤学 | 214篇 |
出版年
2024年 | 16篇 |
2023年 | 127篇 |
2022年 | 138篇 |
2021年 | 280篇 |
2020年 | 353篇 |
2019年 | 351篇 |
2018年 | 346篇 |
2017年 | 369篇 |
2016年 | 376篇 |
2015年 | 370篇 |
2014年 | 484篇 |
2013年 | 788篇 |
2012年 | 505篇 |
2011年 | 452篇 |
2010年 | 416篇 |
2009年 | 404篇 |
2008年 | 361篇 |
2007年 | 400篇 |
2006年 | 318篇 |
2005年 | 354篇 |
2004年 | 288篇 |
2003年 | 303篇 |
2002年 | 266篇 |
2001年 | 278篇 |
2000年 | 247篇 |
1999年 | 222篇 |
1998年 | 211篇 |
1997年 | 184篇 |
1996年 | 162篇 |
1995年 | 182篇 |
1994年 | 162篇 |
1993年 | 117篇 |
1992年 | 113篇 |
1991年 | 117篇 |
1990年 | 105篇 |
1989年 | 86篇 |
1988年 | 99篇 |
1987年 | 83篇 |
1986年 | 61篇 |
1985年 | 113篇 |
1984年 | 104篇 |
1983年 | 71篇 |
1982年 | 77篇 |
1981年 | 63篇 |
1980年 | 46篇 |
1979年 | 21篇 |
1978年 | 12篇 |
1977年 | 13篇 |
1976年 | 14篇 |
1974年 | 3篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
41.
42.
43.
44.
Thrombosis triggered by severe arterial lesions is inhibited by oral administration of a glycoprotein IIb/IIIa antagonist 总被引:2,自引:0,他引:2
J. J. BADIMON B. MEYER L. P. FEIGEN D. A. BARON J. H. CHESEBRO V. FUSTER & L. BADIMON 《European journal of clinical investigation》1997,27(7):568-574
Platelet aggregation and thrombosis play an important role in the onset of acute coronary events. Regardless of the stimulus for activation, platelet thrombus formation is ultimately regulated through the IIb/IIIa receptor complex. The effects of oral administration of xemilofiban, a non-peptide mimetic of the RGDF sequence of the IIb/IIIa receptor complex, on thrombus formation were evaluated in a canine model. Xemilofiban significantly reduced platelet deposition on severely damaged arterial wall. Platelet deposition was reduced at both low (13 ± 1 from 56 ± 18 × 106 platelets cm−2 ; P < 0.05) and high (23 ± 2 from 111 ± 21 × 106 platelets cm−2 ; P < 0.01) shear rates. Platelet deposition was reduced to a monolayer as seen by electron microscopy (platelet–vessel wall interaction). Therefore, the availability of an orally active IIb/IIIa antagonist for chronic use may have significant value in preventing thrombus formation in those clinical situations associated with severe arterial injury, such as atherosclerotic plaque disruption. 相似文献
45.
Summary. Platelet membranes provide procoagulant surfaces for the assembly and expression of the factor X-activating complex and promote the proteolytic activation and assembly of the prothrombinase complex resulting in normal hemostasis. Recent studies from our laboratory and others indicate that platelets possess specific, high-affinity, saturable, receptors for factors XI, XIa, IX, IXa, X, VIII, VIIIa, V, Va and Xa, prothrombin, and thrombin. Studies described in this review support the hypothesis that the factor X-activating complex on the platelet surface consists of three receptors (for the enzyme, factor IXa; the substrate, factor X; and the cofactor, factor VIIIa), the colocalization of which results in a 24 million-fold acceleration of the rate of factor X activation. Whether the procoagulant surface of platelets is defined exclusively by procoagulant phospholipids, or whether specific protein receptors exist for the coagulant factors and proteases, is currently unresolved. The interaction between coagulation proteins and platelets is critical to the maintenance of normal hemostasis and is pathogenetically important in human disease. 相似文献
46.
①目的 观察适量饮酒对健康成年男性的血小板聚集功能及血浆血栓素B2 (TXB2 ) ,6 酮 前列腺素F2a(6 Keto PGF2a)的影响。②方法 将 80例健康成年男性随机分成 4组 ,分别空腹饮用矿泉水、啤酒、干红葡萄酒各 2 0 0mL ,白酒 50mL加矿泉水至 2 0 0mL .于饮前及饮后 2h分别测定血小板的聚集率及解聚率 ,并采血测定血浆TXB2 ,6 Keto PGF2a.③结果 矿泉水组饮后上述指标无变化 (t=0 .0 3~ 0 .84,P >0 .0 5) ;白酒、啤酒、红葡萄酒组饮后血小板聚集率减低 (t=8.1 2~ 2 4 .39,P <0 .0 1 ) ,解聚率升高 (t=2 8.48~ 35 .2 2 ,P <0 .0 1 ) ,血浆TXB2 降低 (t=2 5 .69~ 89.83 ,P <0 .0 1 ) ,而血浆 6 Keto PGF2a升高 (t=2 1 .0 6~ 2 3 .2 9,P <0 .0 1 )。④结论 健康成年男性适量饮酒可减低其血小板聚集功能 ,降低其血浆TXB2 ,提高其血浆 6 Keto PGF2a水平 相似文献
47.
Continuous proteolysis resulting in consumption of major cytoskeletal proteins may be essential for platelet activation and aggregation. In this study we evaluated the effect of a known protease inhibitor, Leupeptin, on agonist induced platelet aggregation and secretion. Platelets exposed to 10 ugs/ml of Leupeptin did not aggregate in response to the action of thrombin (0.2u/ml). However, a concentration of Leupeptin as high as 250 ugs/ml did not prevent arachidonate induced aggregation and secretion. Leupeptin (100 ugs/ml) effectively blocked thrombin (0.2 u/ml) induced elevation of cytosolic calcium, but did not affect arachidonate induced elevation of platelet intracellular calcium levels. At a concentration of 100 ug/ml, Leupeptin effectively blocked thrombin (0.5u/ml) induced clot formation of platelet poor plasma, suggesting that it can exert its effect on thrombin by preventing fibrinogen degradation. Effective Ki for the competitive inhibition of thrombin induced hydrolysis of a chromogenic substrate, S2238, by Leupeptin was 2.4 uM. Leupeptin inhibition of platelet function was reversible by washing platelets free of the polypeptide. Results of our study demonstrate that Leupeptin inhibits thrombin induced platelet activation, probably by interfering with its proteolytic activity on the platelet surface membrane. However, inhibition of platelet surface membrane associated proteases did not prevent activation of platelets by other agonists. 相似文献
48.
检测198例各型乙肝患者血小板功能的五个项目:血小板总数、粘附试验、聚集试验、血块退缩、血小板第3因子有效性,发现各期乙肝患者血小板功能的异常有显著性差异(P<0.01).并提示乙肝患者除有血小板数量的改变外,还有质量的改变,因此,全面的血小板功能检测可作为估计乙肝患者肝损害程度的辅助指标. 相似文献
49.
R. B. Zotz G. Giers B. Maruhn-Debowski & R. E. Scharf 《British journal of haematology》1997,96(1):198-203
Genotyping of platelet alloantigens with the possibility of using any type of cellular material as a source of DNA has become a preferred procedure, particularly in thrombocytopenic patients when platelet counts are too low for phenotyping. Recently human platelet antigen 1 (HPA-1) has been identified as an inherited risk factor for coronary thrombosis. The different detection methods currently used have disadvantages for large-scale DNA diagnosis, including the need for electrophoresis (allele-specific restriction enzyme analysis, amplification with sequence-specific primers) or the potential risk of reduced specificity (allele-specific oligonucleotide hybridization). In this report we describe the adaptation of an automated oligonucleotide ligation assay to genotype HPA-1 in polymerase chain reaction (PCR)-amplified DNA samples. HPA-1a and HPA-1b phenotypes corresponded to the results of the different genotyping assays. The genotypes determined with the ELISA-based PCR-oligonucleotide ligation assay were in 100% concordance with the results obtained by conventional allele-specific restriction enzyme site analysis and PCR amplification with sequence-specific primers. The automated oligonucleotide ligation assay provides a rapid, reliable, nonisotopic method to genotype human platelet antigens that can rapidly be applied to large population screening. 相似文献
50.
J. P. De La Cruz S. Cámara M. A. Frutos F. Sánchez De La Cuesta 《European journal of clinical pharmacology》1992,43(3):307-309
Summary The antiproteinuric effect of the antiplatelet agent dipyridamole has been assessed after inhibiton of thromboxane B2 (TxB2) synthesis in 8 patients with confirmed membranous glomerulonephritis.
There were three study periods, each of 30 days, and 45 days apart, namely a washout period, treatment with dipyridamole 300
mg/d, and dipyridamole 225 mg/d plus aspirin 150 mg/d. On Days 1 and 30 of each study period serum and urine creatinine, 24-h
excretion of protein, creatinine clearance, platelet aggregometry on whole blood and serum TxB2 were measured.
Treatment with dipyridamole alone or with aspirin produced significant inhibition of platelet aggregation and a fall in 24-h
protein excretion; the latter amounted to 54% with dipyridamole alone and 56 % with dipyridamole plus aspirin (NS). Dipyridamole
plus aspirin caused an 82 % reduction in serum TxB2. 相似文献